Skip to search formSkip to main contentSkip to account menu

Cereport

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

RMP-7labradimil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Highly Cited
2004
Highly Cited
2004
Effects of γ- and Hydroxypropyl-γ-cyclodextrins on the Transport of Doxorubicin across an in Vitro Model of Blood-Brain Barrier
Association between doxorubicin (DOX) and γ-cyclodextrin (γ-CD) or hydroxypropyl-γ-CD (HP-γ-CD) has been examined to increase the… 
Review
2003
Review
2003
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
2002
2002
Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
2002
2002
Bradykinin receptor agonist facilitates low-dose Cyclosporine-A protection against 6-hydroxydopamine neurotoxicity
Review
2001
Review
2001
The Development of the Bradykinin Agonist Labradimil as a Means to Increase the Permeability of the Blood-Brain Barrier
AbstractLabradimil (Cereport®; also formerly referred to as RMP-7) is a 9-amino-acid peptide designed for selectivity for the… 
2000
2000
Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
Several experiments studied the effects of i.v. infusions of the bradykinin agonist, Cereport (RMP-7), on permeability of the… 
Highly Cited
1999
Highly Cited
1999
Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas.
OBJECTIVE Animal and human studies have shown increased delivery of radiolabeled compounds across the blood-brain-tumor barrier… 
1999
1999
Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7).
OBJECTIVE Using the well-characterized F98 rat glioma model, the purpose of the present study was to determine whether the… 
1999
1999
Cereport™ (RMP-7) Increases the Permeability of Human Brain Microvascular Endothelial Cell Monolayers1
AbstractPurpose. To study Cereport (RMP-7, bradykinin B2 agonist) effects on human brain microvascular endothelial cell (HBMEC… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)